Skip to main content
Psychopharmacology Bulletin › All Volumes & Issues › VOL 56 No. 3 › Mirtazapine-Induced Asymptomatic Hepatotoxicity:...
COMPLICATED CASE HISTORY

Mirtazapine-Induced Asymptomatic Hepatotoxicity: A Case Report

Rim Sellami, Ines Feki, Jawaher Masmoudi
Psychopharmacology Bulletin 56(3): 161-164, 2026/06/05; https://doi.org/10.64719/pb.18543

Abstract

We report the case of a 27-year-old male who developed elevated liver enzymes during treatment with low-dose mirtazapine for insomnia. Liver function normalized after discontinuation of the drug, supporting a probable drug-induced liver injury (DILI). This case highlights the need for hepatic monitoring during mirtazapine therapy, even at low doses and in asymptomatic patients.

Keywords

hepatoxicity, liver function, mirtazapine

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In
Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Rim Sellami, Ines Feki, Jawaher Masmoudi. Mirtazapine-Induced Asymptomatic Hepatotoxicity: A Case Report. Psychopharmacology Bulletin. 2026/06/05; 56(3):161-164. https://doi.org/10.64719/pb.18543